Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Airlines fall as face weaker summer than in 2020

Fri, 04th Jun 2021 08:57

(Alliance News) - Stock prices in London opened mixed on Friday ahead of the US jobs report for May at 1330 BST, while airlines were under pressure after the UK government moved Portugal to its amber travel list to guard against Covid-19 variants.

The FTSE 100 index was down 2.18 points at 7,062.45. The mid-cap FTSE 250 index was up 8.77 points, or 0.1%, at 22,811.17. The AIM All-Share index was flat at 1,250.44.

The Cboe UK 100 index was down 0.1% at 704.10. The Cboe 250 was down 0.1% at 20,551.76, and the Cboe Small Companies was flat at 15,229.25.

In Paris the CAC 40 was flat, while the DAX 30 in Frankfurt was up 0.2%.

In the FTSE 100, AstraZeneca was up 0.5% after the Anglo-Swedish drugmaker said drug lynparza reduced the risk of breast cancer recurrence by 42% in phase 3 trials.

The Cambridge, England-based firm said that in the adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer, lynparza reduced the risk of recurrence by 42% in the OlympiA phase 3 trial. BRCA refers to the breast cancer gene.

AstraZeneca also said it has appointed Aradhana Sarin as its new chief financial officer. The appointment is conditional upon the closing of the drugmaker's acquisition of Alexion Pharmaceuticals. Sarin, who is currently is CFO of Alexion, will succeed Marc Dunoyer who will step down as CFO and retire from AstraZeneca's board on August 1.

At the other end of the large-caps, British Airways parent International Consolidated Airlines Group was once again among the worst performers, down 2.3%, as the wider travel sector comes under renewed pressure.

Hopes for summer holidays abroad are fading after UK travel rules were tightened amid growing concerns over coronavirus variants and mutations, PA reported. Travel bosses are facing "another lost summer" after Portugal was added to the amber travel list just weeks after the holiday hotspot reopened for British tourists.

Urging caution ahead of the scheduled domestic unlock on June 21, UK Transport Secretary Grant Shapps blamed the move on "a sort of Nepal mutation of the so-called Indian variant" having been detected, and an increased test positivity rate in the country.

Heathrow boss John Holland-Kaye has accused the UK government of "all but guaranteeing another lost summer for the travel sector".

The news comes as it was revealed that the variant first identified in India is now the dominant Covid strain in the UK.

Portugal, including the islands of Madeira and the Azores, will be removed from the green list which exempts the need to quarantine on return from 4am on Tuesday, meaning travellers will be required to self-isolate for 10 days at home.

Budget airlines easyJet, Ryanair and Wizz air were down 2.4%, 1.3% and 2.5%, respectively. AIM-listed Jet2 was 0.2% lower. However, Anglo-German holiday operator Tui was up 0.1%.

Liberum analyst Gerald Khoo commented: "This seems likely to effectively shut down UK international leisure travel for at least the first part of the peak summer season. It seems unlikely that the decision will be reversed quickly. There is now a real risk that flying activity this summer could be weaker than Summer 2020, with concerns about Covid variants outweighing vaccination programme progress.

"The EU is currently pressing ahead with its travel passport scheme, to facilitate travel via vaccination or negative tests. However, the UK is one of the major sources of international tourists, so ongoing tight restrictions here will have a material impact on the airline industry. This supports our cautious stance on the airlines."

On AIM, boohoo Group was up 2.1% after Morgan Stanley upgraded the online fashion retailer to Equal Weight from Underweight.

The Japanese Nikkei 225 index closed down 0.4% on Friday. In China, the Shanghai Composite ended up 0.1%, while the Hang Seng index in Hong Kong was down 0.4%. The S&P/ASX 200 in Sydney closed up 0.5%.

The pound was quoted at USD1.4105 Friday morning, unchanged from USD1.4108 at the London equities close Thursday.

The euro stood at USD1.2110 early Friday, down from USD1.2125 late Thursday. Against the yen, the dollar was trading at JPY110.20, little changed from JPY110.27.

Brent oil was quoted at USD71.57 a barrel on Friday morning, up from USD71.25 late Thursday. Gold was priced at USD1,874.02 an ounce, marginally higher from USD1,869.72.

Friday's economic calendar also has UK construction PMI at 0930 BST and eurozone retail sales at 1000 BST.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.